Literature DB >> 11886487

ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis?

A Vaglio1, L Manenti, L Allegri, F Ferrozzi, D Corradi, C Buzio.   

Abstract

Retroperitoneal fibrosis (RPF) is a disease of unknown aetiology that has sometimes been reported in association with connective tissue disorders and systemic vasculitis. We report here two cases of antineutrophil cytoplasmic antibody (ANCA)-positive RPF showing clinical evidence of rapidly progressive glomerulonephritis. Although treatment with prednisone and cyclophosphamide led to a remission of RPF in both cases, renal function was restored in only one patient and the other progressed to chronic renal failure. The paper reviews the literature concerning ANCA-positive RPF and discusses the relationship between ANCA-positive vasculitis and RPF.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11886487     DOI： 10.1046/j.1365-2796.2002.00948.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


  10 in total

1.  Retroperitoneal fibrosis and c-ANCA positivity.

Authors:  Clio P Mavragani; Michalis Voulgarelis
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

Review 2.  Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature.

Authors:  Hirotoshi Kawashima; Atsunari Utsugi; Asuka Shibamiya; Kazuma Iida; Norihiro Mimura; Hirohumi Ohashi; Ryota Hase; Makio Kawakami; Takao Yanagisawa; Masaki Hiraguri
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

Review 3.  Idiopathic Retroperitoneal Fibrosis.

Authors:  Augusto Vaglio; Federica Maritati
Journal:  J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 10.121

Review 4.  Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature.

Authors:  Giovanni M Rossi; Giacomo Emmi; Domenico Corradi; Maria L Urban; Federica Maritati; Federica Landini; Paola Galli; Alessandra Palmisano; Augusto Vaglio
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 5.  Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature.

Authors:  K Warnatz; A G Keskin; M Uhl; C Scholz; A Katzenwadel; P Vaith; H H Peter; U A Walker
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

Review 6.  Kidney involvement in medium- and large-vessel vasculitis.

Authors:  Federica Maritati; Francesco Iannuzzella; Maria P Pavia; Sonia Pasquali; Augusto Vaglio
Journal:  J Nephrol       Date:  2016-04-20       Impact factor: 3.902

7.  The First Case of Eosinophilic Granulomatosis with Polyangiitis Simultaneously Demonstrating Various Clinical Manifestations with Retroperitoneal Fibrosis and Membranous Nephropathy.

Authors:  Isao Kondo; Yohei Arai; Emi Sakamoto; Daisuke Katagiri; Fumihiko Hinoshita
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

Review 8.  Retroperitoneal fibrosis - the state-of-the-art.

Authors:  Marta Runowska; Dominik Majewski; Mariusz Puszczewicz
Journal:  Reumatologia       Date:  2016-11-28

Review 9.  Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature.

Authors:  Emanuel Della-Torre; Marco Lanzillotta; Corrado Campochiaro; Emanuele Bozzalla; Enrica Bozzolo; Alessandro Bandiera; Elena Bazzigaluppi; Carla Canevari; Giulio Modorati; John H Stone; Angelo Manfredi; Claudio Doglioni
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Retroperitoneal fibrosis with periaortitis: A case report of an unusual form of presentation of granulomatosis with polyangiitis.

Authors:  Elizabeth Manuely González Revilla; Araceli Abad Fernandez; María Teresa Río Ramirez; Sara Calero Pardo; María Antonia Juretschke Moragues
Journal:  Respir Med Case Rep       Date:  2016-08-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.